Search results
Results from the WOW.Com Content Network
The Children's Oncology Group (COG), a clinical trials group supported by the National Cancer Institute (NCI), is the world's largest organization devoted exclusively to pediatric cancer research. [1] The COG conducts a spectrum of clinical research and translational research trials for infants, children, adolescents, and young adults with cancer.
Childhood cancer is cancer in a child. About 80% of childhood cancer cases in high-income countries can be successfully treated via modern medical treatments and optimal patient care. [2] [3] However, only about 10% of children diagnosed with cancer reside in high-income countries where the necessary treatments and care is available.
The objective of cancer screening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and medical imaging. [ 1 ] [ 2 ] The purpose of screening is early cancer detection, to make the cancer easier to treat and extending life expectancy. [ 3 ]
The resolution, introduced by United States Senators Wayne Allard (R-CO) and Hillary Rodham Clinton (D-NY), recognized September 13, 2008, as National Childhood Cancer Awareness Day. [5] An initial proclamation was signed in 1990 by President George H.W. Bush, naming October as National Awareness Month for Children with Cancer. [6]
The study also found that 81% of women want cervical cancer testing options that are more comfortable and less invasive than a pelvic exam, with 73% interested in using a self-collection vaginal ...
Childhood leukemia is the most common childhood cancer, accounting for 29% of cancers in children aged 0–14 in 2018. [1] There are multiple forms of leukemia that occur in children, the most common being acute lymphoblastic leukemia (ALL) followed by acute myeloid leukemia (AML). [ 2 ]
CureSearch for Children's Cancer is an American 501(c)(3) non-profit foundation that funds next-generation research that will lead to safe, effective commercially viable treatments for children with cancer.
The 2002 Best Pharmaceuticals for Children Act, allowed the FDA to request National Institutes of Health-sponsored testing for pediatric drug testing, although these requests are subject to NIH funding constraints. Patent term extensions were offered to manufacturers that conducted trials of drugs that would be used in children. The Pediatric ...